Medical Marijuana, Inc. (MJNA), through its subsidiaries and investment holdings, offers a portfolio of products, services, technology and businesses for the medical marijuana and industrial hemp markets. The Company is in the development-stage. The Company's products range from cannabinoid-based products, to whole plant or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. The Company's services include medical clinic management, and the capitalization and development of cannabis and hemp industries business. Its services include development of cannabinoid-based health and wellness products, and the development of medical-grade cannabinoid compounds. MJNA services include the licensing of its testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal cannabinoid industry.